Synlait Milk Ltd – Recent Corporate Developments

Banking Facility Amendments and Extensions

On 1 March 2026, Synlait Milk Limited announced that it had entered into documentation providing for amendments, waivers and extensions to its syndicated bank facilities. The company cited its latest half‑year performance update and the forthcoming receipt of proceeds from the sale of its North Island assets as the basis for the request. The sale, which remains scheduled for completion on 1 April 2026, is a key component of Synlait’s asset‑divestment strategy. The amendments are intended to support ongoing working‑capital requirements and to provide additional liquidity as the company transitions to a post‑sale capital structure.

Resignation of Executive Director – Charles Fergusson

On 3 March 2026, Synlait confirmed that Charles Fergusson, Director of On‑Farm Excellence, Business Sustainability and Corporate Affairs, had resigned from the Executive Leadership Team. CEO Richard Wyeth acknowledged Fergusson’s contributions, noting that he had been instrumental in guiding the company through multiple challenges and had led the successful project that secured the company’s milk supply last year. Fergusson’s departure follows his appointment as Chief Executive Officer – Global Proteins at Scales Corporation Limited, a move that brings his experience in dairy supply‑chain management to a new role within the broader food‑products industry.

Market Context

  • Stock performance (ASX: SM1) – The share closed at AUD 0.40 on 23 February 2026, after a 52‑week high of AUD 0.935 on 19 March 2025 and a 52‑week low of AUD 0.385 on 16 February 2026.
  • Market capitalization – AUD 241,280,000.
  • Price‑earnings ratio – –6.41, reflecting negative earnings for the reporting period.

Implications

The banking facility extensions provide Synlait with continued access to credit while it completes the sale of its North Island assets. Fergusson’s exit and subsequent appointment at Scales suggest a strategic realignment of Synlait’s executive team, potentially enabling the company to focus on core operational and supply‑chain initiatives. Investors should monitor the progression of the asset sale and any further disclosures regarding the company’s liquidity position and strategic priorities.